Michael Teifel
Hoofd Techniek/Wetenschap/O&O bij AETERNA ZENTARIS INC.
Vermogen: - $ op 30-04-2024
Profiel
Michael Teifel is the founder of Munich Biotech AG, which was founded in 1998.
He held the title of Head-Pharmacology & Toxicology from 1998 to 2004.
Currently, Dr. Teifel is the Chief Scientific Officer & Senior Vice President at Æterna Zentaris, Inc. since 2004.
He is also the Head-Translational Sciences at Cleara Biotech BV.
Previously, Dr. Teifel worked at AEterna Zentaris GmbH from 2004 to 2019, where he held the title of Vice President-Non Clinical Services from 2014 to 2019.
Dr. Teifel obtained his doctorate degree from Technische Universität Darmstadt in 1996.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AETERNA ZENTARIS INC.
-.--% | 12-01-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Michael Teifel
| Bedrijven | Functie | Begin |
|---|---|---|
| AETERNA ZENTARIS INC. | Hoofd Techniek/Wetenschap/O&O | 03-05-2021 |
Cleara Biotech BV
 Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Corporate Officer/Principal | - |
Eerdere bekende functies van Michael Teifel
| Bedrijven | Functie | Einde |
|---|---|---|
AEterna Zentaris GmbH
 AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Corporate Officer/Principal | 01-10-2019 |
Munich Biotech AG
 Munich Biotech AG Pharmaceuticals: MajorHealth Technology Munich Biotech AG manufactures pharmaceuticals. The private company is based in Neuried, Germany. The German company was founded by Michael Teifel. | Oprichter | 01-08-2004 |
Opleiding van Michael Teifel
| Technische Universität Darmstadt | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AETERNA ZENTARIS INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Munich Biotech AG
Munich Biotech AG Pharmaceuticals: MajorHealth Technology Munich Biotech AG manufactures pharmaceuticals. The private company is based in Neuried, Germany. The German company was founded by Michael Teifel. | Health Technology |
AEterna Zentaris GmbH
AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Commercial Services |
Cleara Biotech BV
Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Health Technology |
